These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 11391343)

  • 1. Current efficacy of postexposure prophylaxis against measles with immunoglobulin.
    Endo A; Izumi H; Miyashita M; Taniguchi K; Okubo O; Harada K
    J Pediatr; 2001 Jun; 138(6):926-8. PubMed ID: 11391343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effectiveness of prophylaxis for measles contacts in NSW.
    Sheppeard V; Forssman B; Ferson MJ; Moreira C; Campbell-Lloyd S; Dwyer DE; McAnulty JM
    N S W Public Health Bull; 2009; 20(5-6):81-5. PubMed ID: 19552854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The safety and immunogenicity of a quadrivalent measles, mumps, rubella and varicella vaccine in healthy children: a study of manufacturing consistency and persistence of antibody.
    Lieberman JM; Williams WR; Miller JM; Black S; Shinefield H; Henderson F; Marchant CD; Werzberger A; Halperin S; Hartzel J; Klopfer S; Schödel F; Kuter BJ;
    Pediatr Infect Dis J; 2006 Jul; 25(7):615-22. PubMed ID: 16804432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The optimal dose of disease-specific antibodies for post-exposure prophylaxis of measles and rubella in Australia: new guidelines recommended.
    Young MK; Ng SK; Nimmo GR; Cripps AW
    Expert Opin Drug Metab Toxicol; 2018 Jul; 14(7):663-669. PubMed ID: 29865869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of Intramuscular Immunoglobulin in Unvaccinated Family Members After Household Measles Exposure.
    Salzman MB; Cherry JD
    Clin Infect Dis; 2017 Nov; 65(11):1955-1956. PubMed ID: 29020233
    [No Abstract]   [Full Text] [Related]  

  • 6. Immunogenicity of standard-titer measles vaccine in HIV-1-infected and uninfected Zambian children: an observational study.
    Moss WJ; Scott S; Mugala N; Ndhlovu Z; Beeler JA; Audet SA; Ngala M; Mwangala S; Nkonga-Mwangilwa C; Ryon JJ; Monze M; Kasolo F; Quinn TC; Cousens S; Griffin DE; Cutts FT
    J Infect Dis; 2007 Aug; 196(3):347-55. PubMed ID: 17597448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunogenicity of aerosol measles vaccine given as the primary measles immunization to nine-month-old Mexican children.
    Wong-Chew RM; Islas-Romero R; García-García Mde L; Beeler JA; Audet S; Santos-Preciado JI; Gans H; Lew-Yasukawa L; Maldonado YA; Arvin AM; Valdespino-Gómez JL
    Vaccine; 2006 Jan; 24(5):683-90. PubMed ID: 16154241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of IgG antibody against measles, mumps and rubella in bangladeshi children: a pilot study to evaluate the need for integrated vaccination strategy.
    Sultana R; Rahman MM; Hassan Z; Hassan MS
    Scand J Immunol; 2006 Dec; 64(6):684-9. PubMed ID: 17083626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Humoral and cellular immune response after measles vaccination in Taiwan.
    Huang CL; Yang YH; Wang LC; Lin YT; Tsai YY; Chiang BL
    J Microbiol Immunol Infect; 2005 Jun; 38(3):169-75. PubMed ID: 15986066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postexposure prophylaxis with intravenous immunoglobulin G prevents infants from getting measles.
    Lejeune A; Martin L; Santibanez S; Thee S; Gratopp A; Späth P; Mankertz A; Kallinich T; von Bernuth H
    Acta Paediatr; 2017 Jan; 106(1):174-177. PubMed ID: 27748542
    [No Abstract]   [Full Text] [Related]  

  • 11. Do Australian immunoglobulin products meet international measles antibody titer standards?
    Young MK; Bertolini J; Kotharu P; Maher D; Cripps AW
    Hum Vaccin Immunother; 2017 Mar; 13(3):607-612. PubMed ID: 27763809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Measles and mumps antibody concentrations in newborns and their mothers--follow up first year of life].
    Hohendahl J; Peters N; Hüttermann U; Rieger C
    Klin Padiatr; 2006; 218(4):213-20. PubMed ID: 16819702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of humoral immunity to poliomyelitis, tetanus, hepatitis B, measles, rubella, and mumps in children after chemotherapy.
    Zignol M; Peracchi M; Tridello G; Pillon M; Fregonese F; D'Elia R; Zanesco L; Cesaro S
    Cancer; 2004 Aug; 101(3):635-41. PubMed ID: 15274078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of diphtheria convalescent patients to serve as donors for the production of anti-diphtheria immunoglobulin preparations.
    Bissumbhar B; Rakhmanova AG; Berbers GA; Iakolev A; Nosikova E; Melnick O; Ovtcharenko E; Rümke HC; Ruitenberg EJ
    Vaccine; 2004 May; 22(15-16):1886-91. PubMed ID: 15121299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Failure of intravenous immunoglobulin to affect the recovery of immune function after measles.
    Shieh CC; Hsieh KH
    Pediatr Infect Dis J; 1989 Dec; 8(12):888-91. PubMed ID: 2626291
    [No Abstract]   [Full Text] [Related]  

  • 16. Measles antibody in the children in Ubon Ratchathani province.
    Saipan P; Jiwapaisarnpong T; Pattanadilok S; Loyha Y; Janggajit T
    J Med Assoc Thai; 2001 Apr; 84(4):500-6. PubMed ID: 11460960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protection against challenge with measles virus (MV) in infant macaques by an MV DNA vaccine administered in the presence of neutralizing antibody.
    Premenko-Lanier M; Rota PA; Rhodes GH; Bellini WJ; McChesney MB
    J Infect Dis; 2004 Jun; 189(11):2064-71. PubMed ID: 15143474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measles-mumps-rubella and varicella vaccine responses in extremely preterm infants.
    D'Angio CT; Boohene PA; Mowrer A; Audet S; Menegus MA; Schmid DS; Beeler JA
    Pediatrics; 2007 Mar; 119(3):e574-9. PubMed ID: 17332177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measles HI-antibody levels in Lagos children, Nigeria: a follow-up study to resurgence of measles in Lagos metropolis.
    Oyefolu AO; Omilabu SA
    West Afr J Med; 2001; 20(3):238-42. PubMed ID: 11922159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Age-dependent differences in IgG isotype and avidity induced by measles vaccine received during the first year of life.
    Nair N; Gans H; Lew-Yasukawa L; Long-Wagar AC; Arvin A; Griffin DE
    J Infect Dis; 2007 Nov; 196(9):1339-45. PubMed ID: 17922398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.